Eocene Ltd. (EOCN)
NASDAQ: EOCN · Real-Time Price · USD
2.970
+0.104 (3.63%)
Nov 3, 2026, 12:49 PM EST - Market open
Eocene Market Cap
Eocene has a market cap or net worth of $3.09 million as of November 3, 2026. It is the 46,778th most valuable company in the world and the 6,232nd biggest in the United States. Its market cap has decreased by 57.62% in one year.
Market Cap
3.09M
Enterprise Value
-8.01M
1-Year Change
-57.62%
Global Rank
Country Rank
#6,232 United States
Category
ChartMarket Cap Chart
Since March 13, 2014, Eocene's market cap has decreased from $145.70M to $3.09M, a decrease of -97.88%. That is a compound annual growth rate of -26.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 2.90M | -29.27% |
| Dec 31, 2025 | 4.10M | -14.58% |
| Dec 31, 2024 | 4.80M | 166.67% |
| Dec 29, 2023 | 1.80M | -85.71% |
| Dec 30, 2022 | 12.60M | -72.43% |
| Dec 31, 2021 | 45.70M | -30.44% |
| Dec 31, 2020 | 65.70M | -45.93% |
| Dec 31, 2019 | 121.50M | 23.23% |
| Dec 31, 2018 | 98.60M | -11.33% |
| Dec 29, 2017 | 111.20M | 185.13% |
| Dec 30, 2016 | 39.00M | -53.85% |
| Dec 31, 2015 | 84.50M | 42.98% |
| Dec 31, 2014 | 59.10M | -59.44% |
| Mar 13, 2014 | 145.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Liminatus Pharma | 3.79M |
| NeuroSense Therapeutics | 3.68M |
| Cadrenal Therapeutics | 3.51M |
| GRI Bio | 3.34M |
| 60 Degrees Pharmaceuticals | 3.31M |
| PharmaCyte Biotech | 3.24M |
| Ernexa Therapeutics | 3.22M |
| KALA BIO | 3.20M |